Trends

Brexit and Unitary Patent Update: UK government preparing ratification of Unified Patent Court Agreement

Brexit and Unitary Patent Update: UK government preparing ratification of Unified Patent Court Agreement

Brexit and Unitary Patent Update: UK government preparing ratification of Unified Patent Court Agreement

29.11.2016

First planned for a launch early 2017, the future of the Unitary Patent and the Unified Patent Court (UPC) had become unclear due to the result of the “Brexit” referendum, as explained in our previous newsletter of 24 June 2016. 

To read our June newsletter, please click here

Yesterday, in parallel with the Competitiveness Council, the UK government has now taken position stating that it will “proceed with preparations to ratify the Unified Patent Court Agreement (UPCA)”. According to the UKIPO, the UK will now work with the UPC Preparatory Committee to bring the Unified Patent Court (UPC) into operation as soon as possible.

In her speech, the UK Minister of State for Intellectual Property, Baroness Neville Rolfe, said:

“(…) for as long as we are members of the EU, the UK will continue to play a full and active role. We will seek the best deal possible as we negotiate a new agreement with the European Union. We want that deal to reflect the kind of mature, cooperative relationship that close friends and allies enjoy. We want it to involve free trade, in goods and services. We want it to give British companies the maximum freedom to trade with and operate in the Single Market - and let European businesses do the same in the UK. (…) But the decision to proceed with ratification should not be seen as pre-empting the UK’s objectives or position in the forthcoming negotiations with the EU.”

The subject was also discussed yesterday during the EU Competitiveness Council and the EU Ministers have welcomed the UK announcement, stating that it will “(…) pave the way for the unitary patent protection system to enter into operation as soon as possible in 2017”.

The next months will thus probably be decisive to clear up some uncertainties regarding the launch of the UPC.

Further patent update: requirement for translation abolished in Belgium as from 1 January 2017

In any case, a recent interesting development for patent owners in Belgium is that, as from 1st January 2017, European patents granted in English will not need to be translated in one of the official languages in order to be validated in Belgium anymore.

With the Belgian Act of 29 June 2016, Belgium has indeed taken the necessary steps to bring its legislation in line with the London Agreement on the application of Article 65 EPC1.

The Agreement has already entered into force in the Netherlands since 2008.

 

1Under this Agreement, patent holders no longer have to file a translation for their European patent in the Member States which have at least one official language in common with the EPO (such as Belgium). This aims to reduce the translation costs to validate one EP in other EPO Member States.

Team

Related news

21.03.2019 NL law
15 aspects of Brexit you did not know

Short Reads - A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario.

Read more

20.11.2018 NL law
Seminar 'Personal data from a broader perspective: overlap inside and outside the privacy domain'

Seminar - On 20 November 2018, Stibbe will host a seminar on privacy. Several Stibbe lawyers will discuss personal data from a broader perspective and the overlap that can occur inside and outside the legal privacy domain.

Read more

21.03.2019 EU law
Ignace Vernimme, Floris ten Have and Manuel Campolini are speakers during the Legal Affairs Conference.

Speaking slot - Ignace Vernimme, IP Partner at Stibbe Brussels, moderates a roundtable discussion on 'second medical use patents'. Manuel Campolini, of-counsel at Stibbe Brussels, co-moderates this session. Floris ten Have, Competition and Regulation Partner at Stibbe Amsterdam, chairs a session on opportunities and challenges for biosimilar medicine developers.

Read more

29.01.2019 NL law
Inwerkingtreding Wet bescherming bedrijfsgeheimen

Short Reads - Op 23 oktober 2018 is de Wet bescherming bedrijfsgeheimen in werking getreden. Deze wet strekt tot implementatie van de Richtlijn bedrijfsgeheimen (2016/943/EU) en biedt houders van niet-openbaar gemaakte knowhow en bedrijfsinformatie (bedrijfsgeheimen) verschillende mogelijkheden om maatregelen te treffen tegen het onrechtmatig verkrijgen, gebruiken of openbaar maken van bedrijfsgeheimen.

Read more

03.10.2018 NL law
Thirteen legal tips for start-ups and scale-ups -Takeaways from Stibbe's 'Scale Up Academy Accenture Innovation Awards' legal workshop

Articles - On Thursday August 30, Stibbe, in cooperation with Accenture Innovation Awards 2017 finalist Somnox, hosted a legal workshop as part of the 'Scale Up Academy of the Accenture Innovation Awards'. The purpose of the event was to make start-ups and scale-ups aware of the legal challenges that may arise in their infancy. 

Read more

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring